Harm K. Wijrdeman

1.1k total citations
16 papers, 822 citations indexed

About

Harm K. Wijrdeman is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiation. According to data from OpenAlex, Harm K. Wijrdeman has authored 16 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 4 papers in Radiation. Recurrent topics in Harm K. Wijrdeman's work include Esophageal and GI Pathology (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Esophageal Cancer Research and Treatment (4 papers). Harm K. Wijrdeman is often cited by papers focused on Esophageal and GI Pathology (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Esophageal Cancer Research and Treatment (4 papers). Harm K. Wijrdeman collaborates with scholars based in Netherlands and Germany. Harm K. Wijrdeman's co-authors include Marinus A. Moerland, Jan J. Battermann, Chris J.G. Bakker, Peter D. Siersema, Henk Boot, Ewout W. Steyerberg, Chris J. Mulder, Hugo W. Tilanus, Ernst J. Kuipers and Janny G. Reinders and has published in prestigious journals such as The Lancet, Gastroenterology and Radiology.

In The Last Decade

Harm K. Wijrdeman

16 papers receiving 802 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harm K. Wijrdeman Netherlands	10	532	376	244	223	85	16	822
Avi Eisbruch United States	7	528 1.0×	190 0.5×	442 1.8×	522 2.3×	75 0.9×	7	1.0k
Atsunori Yorozu Japan	20	686 1.3×	272 0.7×	124 0.5×	359 1.6×	59 0.7×	99	913
Dario Zerini Italy	18	753 1.4×	165 0.4×	245 1.0×	595 2.7×	44 0.5×	61	1.1k
Ricardo Sales dos Santos United States	22	1.5k 2.8×	491 1.3×	335 1.4×	143 0.6×	110 1.3×	59	1.9k
Domenico Cante Italy	17	467 0.9×	162 0.4×	312 1.3×	550 2.5×	78 0.9×	49	946
Inger‐Karine K. Kolkman‐Deurloo Netherlands	19	683 1.3×	346 0.9×	253 1.0×	607 2.7×	111 1.3×	47	1.1k
Lon Marsh United States	10	534 1.0×	246 0.7×	305 1.3×	500 2.2×	72 0.8×	12	875
Tobias Hölscher Germany	18	524 1.0×	85 0.2×	378 1.5×	223 1.0×	49 0.6×	55	836
Alfonso Gómez‐Iturriaga Spain	17	630 1.2×	207 0.6×	216 0.9×	256 1.1×	22 0.3×	79	893
Hale Başak Çağlar Türkiye	15	465 0.9×	174 0.5×	159 0.7×	88 0.4×	22 0.3×	42	785

Countries citing papers authored by Harm K. Wijrdeman

Since Specialization

Citations

This map shows the geographic impact of Harm K. Wijrdeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harm K. Wijrdeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harm K. Wijrdeman more than expected).

Fields of papers citing papers by Harm K. Wijrdeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harm K. Wijrdeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harm K. Wijrdeman. The network helps show where Harm K. Wijrdeman may publish in the future.

Co-authorship network of co-authors of Harm K. Wijrdeman

This figure shows the co-authorship network connecting the top 25 collaborators of Harm K. Wijrdeman. A scholar is included among the top collaborators of Harm K. Wijrdeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harm K. Wijrdeman. Harm K. Wijrdeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Broekhoven, Danique L. M. van, Cornelis Verhoef, Sjoerd G. Elias, et al.. (2013). Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis. British journal of surgery. 100(9). 1214–1219. 51 indexed citations

Ubink, Inge, Pieter C. van der Sluis, M.E.I. Schipper, et al.. (2013). Adding Preoperative Radiotherapy Plus Cetuximab to Perioperative Chemotherapy for Resectable Esophageal Adenocarcinoma: A Single-Center Prospective Phase II Trial. The Oncologist. 19(1). 32–33. 7 indexed citations

Meerveld-Eggink, A., Thomas L. Bollen, Harm K. Wijrdeman, & Maartje Los. (2013). [Bone metastases or an insufficiency fracture? Oncology patients reporting pain or showing bone abnormalities on a scan].. PubMed. 157(28). A6098–A6098. 3 indexed citations

Hirdes, Meike M., Jeanin E. van Hooft, Harm K. Wijrdeman, et al.. (2012). Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer. Gastrointestinal Endoscopy. 76(2). 267–274. 21 indexed citations

Moerland, Marinus A., et al.. (2005). Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry. International Journal of Radiation Oncology*Biology*Physics. 63(3). 772–780. 52 indexed citations

Homs, Marjolein Y.V., Ewout W. Steyerberg, W M H Eijkenboom, et al.. (2005). [Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study].. PubMed. 149(50). 2800–6. 6 indexed citations

Moerland, Marinus A., et al.. (2004). Quality of permanent prostate implants using automated delivery with seedSelectron™ versus manual insertion of RAPID Strands™. Radiotherapy and Oncology. 73(1). 49–56. 24 indexed citations

Homs, Marjolein Y.V., Ewout W. Steyerberg, Wilhelmina M.H. Eijkenboom, et al.. (2004). Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. The Lancet. 364(9444). 1497–1504. 325 indexed citations

Homs, Marjolein Y.V., Ewout W. Steyerberg, Wilhelmina M.H. Eijkenboom, et al.. (2003). Is high dose rate brachytherapy an alternative to stent placement in the palliation of malignant dysphagia?ȁa randomized trial. Gastroenterology. 124(4). A104–A104. 2 indexed citations

10.

Moerland, Marinus A., et al.. (2000). The combined use of the natural and the cumulative dose–volume histograms in planning and evaluation of permanent prostatic seed implants. Radiotherapy and Oncology. 57(3). 279–284. 16 indexed citations

11.

Moerland, Marinus A., et al.. (1997). Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. International Journal of Radiation Oncology*Biology*Physics. 37(4). 927–933. 127 indexed citations

12.

Moerland, Marinus A., et al.. (1995). Analysis and correction of geometric distortions in 1.5 T magnetic resonance images for use in radiotherapy treatment planning. Physics in Medicine and Biology. 40(10). 1651–1664. 60 indexed citations

13.

Moerland, Marinus A., et al.. (1995). Evaluation of permanent I-125 prostate implants using radiographs and MRI. Radiotherapy and Oncology. 37. S12–S12. 1 indexed citations

14.

Wijrdeman, Harm K., et al.. (1993). Brain tumor delineation based on CT and MR imaging. Implications for radiotherapy treatment planning.. PubMed. 169(12). 729–33. 36 indexed citations

15.

Sijens, Paul E., Harm K. Wijrdeman, Marinus A. Moerland, et al.. (1988). Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T.. Radiology. 169(3). 615–620. 90 indexed citations

16.

Wijrdeman, Harm K. & C. J. G. Bakker. (1988). Multiple slice MR imaging as an aid in radiotherapy of carcinoma of the cervix uteri. A case report.. PubMed. 164(1). 44–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact